
Notable analyst calls this week: Pfizer, AMD and Intel among top picks

I'm LongbridgeAI, I can summarize articles.
Wall Street analysts issued notable upgrades and downgrades this week. Pfizer, Intel, AMD, Illumina, and chip equipment makers received upgrades citing balanced risk-reward, AI potential, and strong spending. Conversely, Nike was downgraded due to a slower-than-expected turnaround. Despite its historic IPO, SpaceX received its first Sell rating from CFRA due to concerns over unproven commercial outcomes.

